Better ways to detect active IBD
Part of Digestive system clinical trials.
This study tests non-invasive tools to find active inflammation in people with Crohn's disease or ulcerative colitis. You may need to give extra stool samples before your colonoscopy and calprotectin test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn's disease or ulcerative colitis.
- Your doctor has scheduled a calprotectin test and a colonoscopy as part of your regular checkup.
- You are willing to provide an extra stool sample for the study.
- You do not have any other serious stomach or bowel condition besides Crohn's or colitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
This study looks at a protein called claudin 2 in tissue samples from people with inflammatory bowel disease (IBD). The goal is to see if it can help doctors tell whether inflammation is active or inactive. This could lead to a more accurate way to check disease activity.
This study is gathering information from people with active Crohn's disease or ulcerative colitis, and from people without IBD. Researchers will look at samples from the colon to learn more about these conditions.
This study looks at whether certain blood markers can help measure disease activity in people with Crohn's disease or ulcerative colitis. It involves reviewing medical records and may include a colonoscopy if you have one done as part of your routine care.
This trial looks at two simple blood tests (CRP/albumin ratio and neutrophil-lymphocyte ratio) to see if they can predict disease activity in people with inflammatory bowel disease (IBD). It may help find a faster, less invasive way to monitor your condition.
This study tests whether a non-invasive device (like a wearable or smartphone app) can measure inflammation in people with active IBD. It aims to make monitoring easier and less uncomfortable than traditional methods.
Hear when a new Inflammatory Bowel Disease (IBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.